Carisma Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
June 27, 2018
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$53,000,000

Company Info
Company Description
Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.
Market
Therapeutics for solid tumor patients
Location
Philadelphia, PA, USA
Coinvestors
AbbVie Biotech Ventures, Agent Capital, Grazia Equity, HealthCap, IP Group, MRL Ventures Fund, Penn Medicine, TPG Biotech

Links